The international surgical journal with global reach

Surgical morbidity and mortality from the multicenter randomized controlled NeoRes II Trial. Standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg 2020; 272: 684-689.

Published: 9th February 2021

Authors: Nilsson K, Klevebro F, Rouvelas I, Lindblad M, Szabo E, Halldestam I et al.


In this study that included 249 patients, there was no difference in the rate of overall or severe complications, whether surgery was done 4-6 or 10-12 weeks after neoadjuvant chemoradiotherapy. All other perioperative outcomes were similar.

Pubmed Link